Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new colloidal lipidic system for gene therapy.

A Fahr1, K Müller, Th Nahde

  • 1Department of Pharmaceutical Technology, University of Jena, D-07743 Jena, Germany. alfred.fahr@uni-jena.de

Journal of Liposome Research
|February 27, 2003
PubMed
Summary

Researchers developed novel Artificial Virus Particles (AVPs) for gene therapy. These targeted AVPs efficiently deliver genetic material to melanoma cells, offering a promising new treatment approach.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polysaccharide conjugates surpass monosaccharide ligands in hepatospecific targeting - Synthesis and comparative in silico and in vitro assessment.

Carbohydrate research·2021
Same author

Is binge-watching addictive? Effects of motives for TV series use on the relationship between excessive media consumption and problematic viewing habits.

Addictive behaviors reports·2021
Same author

Lipid nanoconstructs for superior hepatoprotection: In vitro assessments as predictive tool for in vivo translation.

International journal of pharmaceutics·2020
Same author

Scattered Light and Other Corrections in Absorption Coefficient Measurements in the Vacuum Ultraviolet: A Systems Approach.

Journal of research of the National Institute of Standards and Technology·2017
Same author

Optimizing Complex Kinetics Experiments Using Least-Squares Methods.

Journal of research of the National Institute of Standards and Technology·2017
Same author

[Severe pneumococcal infections in the elderly - preventable by vaccination].

Zeitschrift fur Gerontologie und Geriatrie·2012

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Nanomedicine

Background:

  • Gene therapy requires efficient and targeted delivery vectors.
  • Current viral vectors face challenges with toxicity and immunogenicity.
  • Liposomal vectors offer a non-viral alternative with potential for modification.

Purpose of the Study:

  • To develop a novel, non-viral liposomal vector for targeted gene delivery.
  • To enhance vector specificity for melanoma cells.
  • To evaluate the efficacy of the vector system in delivering genetic material.

Main Methods:

  • Artificial Virus Particles (AVPs) were engineered based on retroviral envelope composition.
  • DNA was condensed using low molecular weight branched polyethyleneimine (PEI).

Related Experiment Videos

  • AVPs were functionalized with cyclic RGD peptide ligands for targeting alphavbeta3-integrins and utilized a tyrosinase promoter for melanoma cell specificity.

    • Main Results:

    • AVPs are serum-resistant, non-toxic, and smaller than 200 nm.
    • RGD-targeted AVPs demonstrated selectivity for tumor endothelial and melanoma cells expressing alphavbeta3-integrins.
    • The tyrosinase promoter enhanced specificity for melanoma cells, enabling efficient genetic material delivery.

    Conclusions:

    • Artificial Virus Particles represent a novel and effective liposomal vector system for gene therapy.
    • Targeted AVPs show significant potential for selective delivery to melanoma cells.
    • This vector system offers a promising platform for developing advanced melanoma treatments.